Medical Technology Enterprise Consortium

Medical Technology Enterprise Consortium, doing business as Mtec, operates as a nonprofit federal medical technology accelerator and prototype development platform under Other Transaction Authority, functioning exclusively as a prime contractor (100% of recent awards) with the Defense Health Agency, Army Medical Command, and Navy Bureau of Medicine and Surgery to rapidly prototype and field innovative medical solutions for military healthcare applications.

Mtec is registered as a nonprofit corporation based in Summerville, South Carolina, with headquarters at 315 Sigma Drive. The organization has no SBA small business designations and competes full-and-open across all federal customers without set-asides. Mtec's work is grounded in medical technology prototype development, operational medicine, trauma care, regenerative medicine, infectious disease diagnostics, wearable diagnostics, advanced wound care, and austere environment medical capabilities. Recent representative work includes a $28.1 million Other Transaction Order from the Defense Health Agency for precision nutrition research and prototype development supporting Special Operations Forces (MTEC-25-04-MULTITOPIC-034, awarded July 10, 2025); a $53.67 million task order for the National Disaster Medical System Modular/Convertible Capability Pilot incorporating proposals from Deloitte, University of California Davis, and University of Colorado Denver (awarded September 26, 2023); a $57.8 million Armed Forces Institute for Regenerative Medicine research project (awarded September 15, 2023); and a $36.5 million SUCCOR Combat Foam for Large Burn Wounds prototype project (MTEC-21-02-FFBT-026, awarded December 7, 2021). Mtec's portfolio also spans $25.98 million for Warfighter Brain Health Technology integration, $21.15 million for modeling metabolic energy expenditure of dismounted female warfighters in multistressor environments, and $22.17 million for clinical studies in Ukraine.

Customer concentration is heavily anchored to Department of Defense medical agencies. The Defense Health Agency dominates both volume and dollars—121 awards carrying $1.15 billion in combined potential value across Mtec's recent award footprint. The Army Medical Command follows with 63 awards valued at $358.1 million combined, while the Navy Bureau of Medicine and Surgery holds 7 awards worth $88.7 million. The Uniformed Services University of the Health Sciences and Defense Threat Reduction Agency round out the customer set with 3 awards each, valued at $45.9 million and $11.3 million respectively. These five agencies account for 100% of Mtec's recent award coverage.

Mtec operates under a single dominant parent vehicle: an Other Transaction IDV with the Defense Health Agency valued at $3.47 billion, awarded January 11, 2024, which has generated 194 task orders carrying $1.61 billion in combined potential value. This vehicle is titled "Enabling Nighttime Austere Resuscitative and Surgical Care Using Night Vision" in partnership with the University of Iowa and serves as the contracting mechanism for rapid prototype development across multiple Department of Defense agencies without individual competitive procurements. The IDV structure enables Mtec to issue task orders across the organization's consortium network without traditional FAR procurement constraints.

Activity has grown substantially over the past five years, with 22 awards in 2022 expanding to 39 awards in 2024; recent activity showed 23 awards in 2025. The organization faces a significant recompete cliff: 88 awards carrying combined potential value of $801.2 million reach ultimate completion within the next twenty-four months and therefore face recompete or re-obligation in that window. This represents roughly 48% of Mtec's total footprint by dollar value.

Mtec functions as a consortium platform and does not execute work as a subcontractor to other primes; instead, Mtec mobilizes partnerships with universities and private sector entities as consortia members to perform the underlying prototype development. Named academic and industry consortia members include the University of Iowa (night vision surgical care), University of Minnesota (regenerative rehabilitation), University of North Carolina Chapel Hill (SWIFT warfighter function), Northwestern University and Wake Forest University Health Sciences (prototype projects), University of Pittsburgh (corneal injury regenerative therapy), and private sector partners including Arete Associates (battlefield remote medical sensing), Moonrise Medical Inc., Safi Biotherapeutics Inc., Plas-Free Ltd., DesiCorp Inc., OmniOx Inc., Maxwell Biosciences Inc., and others. Mtec serves as the prime vehicle through which these partners execute their work under Other Transaction agreements rather than direct federal contracts.

The organization's award footprint shows 143 awards in the Health R&D Services/Health Care - Other/Experimental Development PSC category, with an additional 50 awards in R&D-Medical/Other (Advanced Development), indicating a portfolio concentrated on early-stage prototype development and experimental medical research rather than production or fielded systems. No set-asides apply across the entire footprint. Mtec was registered in SAM.gov in December 2015 and has operated continuously as a nonprofit federal medical technology development platform for the Defense Health Agency and subordinate commands since that time, with total obligated spend reaching $1.52 billion (92% of the combined potential value across 197 awards).